3:30 am - 5:00 am

Charting the CRISPR IP landscape


The CRISPR patent landscape beyond the United States: Europe, Asia and the rest of the world
The future of CRISPR patent licensing
Patentability issues surrounding gene-editing technologies

8:00 am - 9:00 am

Registration & Networking

Pre function Area

9:00 am - 10:30 am

Critical issues on Pharma Patenting for ANDA and NDA applications


Common Filing Deficiencies in Abbreviated New Drug Applications (ANDA)
PARA – IV Filing & 180 days market exclusivity
Is 505(b)(2) filing a safer strategy: Avoiding a known risk?
Hatch-Waxman and BPCIA Developments

10:30 am - 11:30 am

Networking Coffee Break

Pre function Area

11:00 am - 12:30 pm

Regulatory provisions for marketing of Patented Drugs in India


Clinical Trials, access to medicines and the regulatory provisions in India
Patient Assistance Program (PAP) and differential pricing

12:30 pm - 1:30 pm

Networking Lunch Break

Pre function Area

1:30 pm - 3:00 pm

Public Health Issues & Compulsory Licensing


- Compulsory licensing, price controls, and access to patented foreign products
- Antitrust, Market Exclusivity, and Transparency in the Pharmaceutical Industry

Speaker -
- Ms. Uma Baskaran, Consultant, Krishna & Saurastri Associates LLP - Compulsory licensing, price controls and access to patented foreign products

Uma Baskaran

3:00 pm - 3:30 pm

Networking Coffee Break

Pre function Area

For Any Queries Contact Us

Contact Us